Keck School Faculty

Mark Swanson, MD
Mark Swanson, MD
Assistant Professor Of Clinical Otolaryngology-Head and Neck Surgery
Otolaryngology
1510 San Pablo Street Health Sciences Campus Los Angeles
Mark Swanson, MD is a fellowship trained head and neck surgeon. After completing medical school at the Ohio State University, he entered a residency in Otolaryngology at University of Southern California. He continued his training with a fellowship in cancer and reconstructive surgery at the University of Miami, and returned to USC to join the faculty at Keck Medical Center. His expertise is in treatment of benign and malignant tumors of the mouth, throat, salivary glands, neck, and thyroid gland. He utilizes advanced robotic, organ preservation, and microvascular reconstructive techniques to maximize quality of life after treatment.

Dr. Swanson works in a multi-disciplinary team including surgeons, radiation oncologists, medical oncologists, and speech/swallow therapists to provide complete care for head and neck diseases.

In addition to treating patients, Dr. Swanson has a research interest in oncologic and quality of life outcomes in head and neck cancers. He focuses on swallowing and voice outcomes after cancer treatments, and is working to provide optimal cancer outcomes while preserving unaffected tissues.

University of Miami: Otolaryngology Fellow Teaching Award, 2016-2017

University of Southern California: Cancer Prevention and Early Detection Community Service Grant, 2014-2015

The Ohio State University: Outstanding Academic Merit, 2009-2010

The Ohio State University: Landachre Research Honors Society, 2008-2009

The Ohio State University: Alpha Omega Alpha Honor Society, 2007-2011

Transoral surgery vs intensity-modulated radiotherapy for early supraglottic cancer: a systematic review Curr Opin Otolaryngol Head Neck Surg. 2017 Apr; 25(2):133-141. . View in PubMed

The Role of HPV in Head and Neck Cancer Stem Cell Formation and Tumorigenesis Cancers (Basel). 2016 Feb 19; 8(2). . View in PubMed

ABCLOVE: Voice therapy outcomes for patients with head and neck cancer Head Neck. 2016 04; 38 Suppl 1:E1810-3. . View in PubMed

Use of Octreotide for the Management of Chyle Fistula Following Neck Dissection JAMA Otolaryngol Head Neck Surg. 2015 Aug; 141(8):723-7. . View in PubMed

Rationale for combined blockade of PD-1 and CTLA-4 in advanced head and neck squamous cell cancer—review of current data Oral Oncol. 2015 Jan; 51(1):12-5. . View in PubMed

Diagnosis and management of merkel cell carcinoma of the head and neck: current trends and controversies Cancers (Basel). 2014 Jun 27; 6(3):1256-66. . View in PubMed

Powered by SC CTSI
Go to Top